BD BBL Moxifloxacin Test Discs Recalled for Susceptibility Testing Inaccuracy
BD BBL Sensi Disc Moxifloxacin test discs are recalled due to possible failures in antibiotic susceptibility testing accuracy. Test failures could lead to delayed diagnosis or inappropriate antibiotic selection.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall with no reported illnesses or injuries. As a risk-of-harm product where injury has not yet been reported, it meets the criterion for High severity per the rubric.
Plain-English summary
BD BBL Sensi Disc Moxifloxacin-5 ug is a laboratory diagnostic test disc used for antibiotic susceptibility testing of H. influenzae. Becton Dickinson & Co. has recalled 2,363,168 units distributed domestically nationwide and internationally.
The recall addresses a possibility of reproducibility, accuracy, and quality control failures in the antibiotic susceptibility testing process. Test failures could result in product discard, delayed test results, or adverse diagnostic outcomes including delayed diagnosis, inappropriate antibiotic selection, or extended antibiotic treatment duration.
The recalled product
- Product
- BD BBL Sensi Disc Moxifloxacin- 5 ug, used for semi-quantitative in vitro susceptibility testing. Catalog Number 231758¿
- Manufacturer
- Becton Dickinson & Co.
- Hazard
- diagnostic-inaccuracy
- delayed-diagnosis
- inappropriate-antibiotic
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- SevereT-Lok Bone Marrow Tray Kits Recalled for Sterility Testing Failure
FDA (Devices) · 2026-07-22
- SevereMedtronic Bio-Medicus Adult Cannula Kit Recalled for Foreign Material
FDA (Devices) · 2026-07-22
- SevereAbiomed Impella CP Introducer Kit heart pump accessory recall
FDA (Devices) · 2026-07-22
- HighOlympus Toomey Evacuator 50cc with Adaptor sterilization recall
FDA (Devices) · 2026-07-22
- HighVasoview Hemopro 2 Endoscopic Vessel Harvesting System Recall
FDA (Devices) · 2026-07-22